Rubius Therapeutics, Inc.

DEUTSCHE BANK AG\

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

150,000

Value ($000)

26

Weight

0.0%

2018 Q3 - 2022 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	26	0.0%	150,000	12/31/2022
2022 Q3	11/14/2022	65	0.0%	150,000	9/30/2022
2022 Q2	8/11/2022	128	0.0%	150,000	6/30/2022
2022 Q1	5/13/2022	147	0.0%	26,766	3/31/2022
2021 Q4	2/16/2022	489	0.0%	50,514	12/31/2021
2021 Q3	11/4/2021	921	0.0%	51,542	9/30/2021
2021 Q2	8/11/2021	1,205	0.0%	49,390	6/30/2021
2021 Q1	5/13/2021	1,175	0.0%	44,360	3/31/2021
2020 Q4	2/16/2021	361	0.0%	47,602	12/31/2020
2020 Q3	11/12/2020	206	0.0%	41,222	9/30/2020
2020 Q2	8/13/2020	112	0.0%	18,676	6/30/2020
2020 Q1	5/14/2020	56	0.0%	12,619	3/31/2020
2019 Q4	2/14/2020	245	0.0%	25,917	12/31/2019
2018 Q3	12/21/2021	662	—	27,564	9/30/2018